More than 600 million people have been infected with SARS-CoV-2 with most of them experiencing mild disease. We know that critically ill COVID-19 survivors, however, have a high risk of readmission, death after discharge, or exacerbation of chronic illness. But, what about COVID-19 survivors with moderate or the more common mild infections? Dr. Lefebre will review the data on the increased mortality of COVID-19 survivors and discuss the syndrome commonly known as Long COVID, and the potential impacts on insurance. 

Speaker:
Dr John Lefebre, VP, Senior Technical Global Medical Director, RGA